Olin, Huntsman to merge; >$400M synergy case
Olin and Huntsman announced an all-stock merger of equals to form OlinHuntsman Corporation, creating a combined company with >$12 billion in pro forma 2025 revenue.
Rhea-AI Filing Summary
Olin and Huntsman announced an all-stock merger of equals to form OlinHuntsman Corporation, creating a combined company with >$12 billion in pro forma 2025 revenue. Huntsman shareholders will receive 0.5476 Olin shares per Huntsman share, leaving Olin holders with ~54.5% and Huntsman holders with ~45.5% of the combined company.
The companies expect >$400 million of cost synergies and integration benefits (including ~$300 million achievable within 24 months and an additional ~$100 million tied to 2031 contract expirations). Pro forma adjusted EBITDA is shown at ~$1.3 billion including synergies; pro forma net leverage is estimated at 4.6x year-end 2025 (approx. 3.2x with full synergy implementation). The transaction is expected to close in H1 2027, subject to regulatory and shareholder approvals.
Positive
- None.
Negative
- None.
Insights
Merger combines upstream chlorine/caustic scale with downstream specialty capabilities.
The announced all-stock merger creates a vertically integrated chemicals platform linking Olin’s chlor-alkali and feedstock positions with Huntsman’s downstream polyurethanes, amines and advanced materials. The companies present a quantified synergy case: >$400M total, ~ $300M expected early and $100M tied to contract expirations in 2031.
Key dependencies include regulatory approvals, successful integration execution, and realization of procurement and operations synergies. Subsequent filings (the Form S-4/joint proxy) will provide transaction mechanics, governance and dilution detail.
Pro forma leverage and cash flow priorities center on deleveraging and disciplined capital allocation.
On a 2025 pro forma basis the presentation cites ~$12.5B revenue and ~$1.3B adjusted EBITDA including synergies. Management highlights pro forma net leverage of 4.6x (year-end 2025) or ~3.2x post-synergies, a blended cost of debt ~5%, and maintenance capex of ~$400M per year.
Planned initial cash priorities are deleveraging, maintaining a stable dividend, and funding high-return growth. Realized cash-tax benefits from NOL acceleration (~$125M) are disclosed separately from synergy totals.
Key Figures
Key Terms
Merger of equals financial
Adjusted EBITDA financial
Net operating loss (NOL) acceleration tax/regulatory
ECU (electrochemical unit) technical
MDI (methylene diphenyl diisocyanate) technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the exchange ratio and ownership split in the Olin–Huntsman deal (HUN)?
How large are the announced synergies and their timing?
What are the pro forma financial metrics disclosed for the combined company?
What is the expected transaction timing and key closing conditions?
How will the combined company prioritize capital allocation?
AI-generated analysis. How Rhea-AI works. Not financial advice.